Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Parasites & Vectors
|
June 13, 2020
A European field assessment of the efficacy of fluralaner (Bravecto<sup>®</sup>) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
Ivo Petersen, Rafael Chiummo, Eva Zschiesche, et al.
Gastroenterology & Hepatology
|
April 24, 2015
Effects of statins on the risk of hepatocellular carcinoma
Pejman G Mansourian, Masato Yoneda, M Krishna Rao, et al.
Frontiers in Medicine
|
May 28, 2019
When Parallel Roads Meet: Orchestrating Collaborations Between Regulatory, Ethical, and Business Partners in Translational Medicine
Uri Tabori, Joseph Ferenbok, Emmanuel Thomas, et al.
Advances in Therapy
|
June 7, 2023
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
Anthony Martinez, Wei-Han Cheng, Steven E Marx, et al.
Parasites & Vectors
|
June 27, 2018
In vitro activity of fluralaner and commonly used acaricides against Dermanyssus gallinae isolates from Europe and Brazil
Emmanuel Thomas, Hartmut Zoller, Gabriele Liebisch, et al.
Plos One
|
November 19, 2020
Assessment of laying-bird welfare following acaricidal treatment of a commercial flock naturally infested with the poultry red mite (Dermanyssus gallinae)
Déborah Temple, Xavier Manteca, Damián Escribano, et al.
Differentiation; Research in Biological Diversity
|
April 8, 2018
Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules
Faizal Z Asumda, Konstantinos E Hatzistergos, Derek M Dykxhoorn, et al.
Journal of Virology
|
November 22, 2013
Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection
Jessica Brownell, Jacob Bruckner, Jessica Wagoner, et al.
Gastroenterology
|
January 18, 2012
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
Emmanuel Thomas, Veronica D Gonzalez, Qisheng Li, et al.
Journal of Translational Medicine
|
June 30, 2018
Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population
Alexandra DeBose-Scarlett, Raymond Balise, Deukwoo Kwon, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Parasites & Vectors
|
June 13, 2020
A European field assessment of the efficacy of fluralaner (Bravecto<sup>®</sup>) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
Ivo Petersen, Rafael Chiummo, Eva Zschiesche, et al.
Gastroenterology & Hepatology
|
April 24, 2015
Effects of statins on the risk of hepatocellular carcinoma
Pejman G Mansourian, Masato Yoneda, M Krishna Rao, et al.
Frontiers in Medicine
|
May 28, 2019
When Parallel Roads Meet: Orchestrating Collaborations Between Regulatory, Ethical, and Business Partners in Translational Medicine
Uri Tabori, Joseph Ferenbok, Emmanuel Thomas, et al.
Advances in Therapy
|
June 7, 2023
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
Anthony Martinez, Wei-Han Cheng, Steven E Marx, et al.
Parasites & Vectors
|
June 27, 2018
In vitro activity of fluralaner and commonly used acaricides against Dermanyssus gallinae isolates from Europe and Brazil
Emmanuel Thomas, Hartmut Zoller, Gabriele Liebisch, et al.
Plos One
|
November 19, 2020
Assessment of laying-bird welfare following acaricidal treatment of a commercial flock naturally infested with the poultry red mite (Dermanyssus gallinae)
Déborah Temple, Xavier Manteca, Damián Escribano, et al.
Differentiation; Research in Biological Diversity
|
April 8, 2018
Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules
Faizal Z Asumda, Konstantinos E Hatzistergos, Derek M Dykxhoorn, et al.
Journal of Virology
|
November 22, 2013
Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection
Jessica Brownell, Jacob Bruckner, Jessica Wagoner, et al.
Gastroenterology
|
January 18, 2012
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
Emmanuel Thomas, Veronica D Gonzalez, Qisheng Li, et al.
Journal of Translational Medicine
|
June 30, 2018
Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population
Alexandra DeBose-Scarlett, Raymond Balise, Deukwoo Kwon, et al.
Page
of 8